Precision Oncology Market Size Was Valued at USD 76.96 Billion in 2023 and is Projected to Reach USD 208.33 Billion by 2032, Growing at a CAGR of 11.7% From 2024-2032.
Precision oncology is a rapidly evolving field within cancer care that tailors treatment strategies based on the unique genetic and molecular characteristics of an individual's cancer. This approach aims to optimize therapeutic outcomes by identifying specific genetic alterations driving the growth of cancer cells and targeting them with precision therapies.